Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 49

1.

Improving topical non-melanoma skin cancer treatment: In vitro efficacy of a novel guanosine-analog phosphonate.

Ali-von Laue C, Zoschke C, Do N, Lehnen D, Küchler S, Mehnert W, Blaschke T, Kramer KD, Plendl J, Weindl G, Korting HC, Hoeller Obrigkeit D, Merk HF, Schäfer-Korting M.

Skin Pharmacol Physiol. 2014;27(4):173. doi: 10.1159/000354118. Epub 2014 Feb 5.

PMID:
24503861
2.

Secondhand smoke policies at state and county fairs.

Mage C, Goldstein AO, Colgan S, Skinner B, Kramer KD, Steiner J, Staples AH.

N C Med J. 2010 Sep-Oct;71(5):409-12.

PMID:
21473537
3.

Drug release and skin penetration from solid lipid nanoparticles and a base cream: a systematic approach from a comparison of three glucocorticoids.

Schlupp P, Blaschke T, Kramer KD, Höltje HD, Mehnert W, Schäfer-Korting M.

Skin Pharmacol Physiol. 2011;24(4):199-209. doi: 10.1159/000324053. Epub 2011 Feb 24.

PMID:
21346400
4.

Evaluation of a direct mailing campaign to increase physician awareness and utilization of a quitline fax referral service.

Mathew M, Goldstein AO, Kramer KD, Ripley-Moffitt C, Mage C.

J Health Commun. 2010 Dec;15(8):840-5. doi: 10.1080/10810730.2010.522223.

PMID:
21170786
5.

Interaction of drug-carrier systems with targets--a study using atomic force microscopy.

Blaschke T, Spangenberg T, Schlupp P, Dathe M, Szcymczak W, Mehnert W, Korting HC, Thalhammer S, Niehus H, Schäfer-Korting M, Kramer KD.

Pharmazie. 2010 Sep;65(9):657-64.

PMID:
21038842
6.

Influence of a tobacco-free hospital campus policy on smoking status of hospital employees.

Ripley-Moffitt C, Viera AJ, Goldstein AO, Steiner JB, Kramer KD.

Am J Health Promot. 2010 Sep-Oct;25(1):e25-8. doi: 10.4278/ajhp.090223-ARB-78.

PMID:
20809822
7.

Statewide diffusion of 100% tobacco-free college and university policies.

Lee JG, Goldstein AO, Kramer KD, Steiner J, Mathew M, Ezzell MM, Shah V.

Tob Control. 2010 Aug;19(4):311-7. doi: 10.1136/tc.2009.032888. Epub 2010 May 14. Erratum in: Tob Control. 2011 Jan;20(1):63. Matthew, M [corrected to Mathew, M]. Tob Control. 2010 Dec;19(6):522. Matthew, M [added].

PMID:
20472575
8.

SLN for topical application in skin diseases--characterization of drug-carrier and carrier-target interactions.

Küchler S, Herrmann W, Panek-Minkin G, Blaschke T, Zoschke C, Kramer KD, Bittl R, Schäfer-Korting M.

Int J Pharm. 2010 May 10;390(2):225-33. doi: 10.1016/j.ijpharm.2010.02.004. Epub 2010 Feb 11.

PMID:
20153414
9.

State adoption of 100% smoke-free acute non federal hospital campus policies.

Goldstein AO, Steiner J, McCullough A, Kramer KD, Okun MF.

Int J Environ Res Public Health. 2009 Nov;6(11):2793-9. doi: 10.3390/ijerph6112793. Epub 2009 Nov 10.

10.

Smoking as a vital sign: prompts to ask and assess increase cessation counseling.

McCullough A, Fisher M, Goldstein AO, Kramer KD, Ripley-Moffitt C.

J Am Board Fam Med. 2009 Nov-Dec;22(6):625-32. doi: 10.3122/jabfm.2009.06.080211.

11.

Influences of opioids and nanoparticles on in vitro wound healing models.

Wolf NB, Küchler S, Radowski MR, Blaschke T, Kramer KD, Weindl G, Kleuser B, Haag R, Schäfer-Korting M.

Eur J Pharm Biopharm. 2009 Sep;73(1):34-42. doi: 10.1016/j.ejpb.2009.03.009. Epub 2009 Apr 1.

PMID:
19344759
12.

Nanoparticles for skin penetration enhancement--a comparison of a dendritic core-multishell-nanotransporter and solid lipid nanoparticles.

Küchler S, Radowski MR, Blaschke T, Dathe M, Plendl J, Haag R, Schäfer-Korting M, Kramer KD.

Eur J Pharm Biopharm. 2009 Feb;71(2):243-50. doi: 10.1016/j.ejpb.2008.08.019. Epub 2008 Aug 30.

PMID:
18796329
13.

Structure and dynamics of drug-carrier systems as studied by parelectric spectroscopy.

Blaschke T, Kankate L, Kramer KD.

Adv Drug Deliv Rev. 2007 Jul 10;59(6):403-10. Epub 2007 May 3.

PMID:
17573146
14.

Interaction of drug molecules with carrier systems as studied by parelectric spectroscopy and electron spin resonance.

Braem C, Blaschke T, Panek-Minkin G, Herrmann W, Schlupp P, Paepenmüller T, Müller-Goyman C, Mehnert W, Bittl R, Schäfer-Korting M, Kramer KD.

J Control Release. 2007 May 14;119(1):128-35. Epub 2007 Feb 8.

PMID:
17382423
15.

Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake.

Stecová J, Mehnert W, Blaschke T, Kleuser B, Sivaramakrishnan R, Zouboulis CC, Seltmann H, Korting HC, Kramer KD, Schäfer-Korting M.

Pharm Res. 2007 May;24(5):991-1000. Epub 2007 Mar 20.

PMID:
17372681
16.

The microwave absorption of emulsions containing aqueous micro- and nanodroplets: a means to optimize microwave heating.

Holtze C, Sivaramakrishnan R, Antonietti M, Tsuwi J, Kremer F, Kramer KD.

J Colloid Interface Sci. 2006 Oct 15;302(2):651-7. Epub 2006 Jul 14.

PMID:
16930614
17.

Organ mapping using parelectric spectroscopy.

Blaschke T, Sivaramakrishnan R, Gross M, Kramer KD.

Phys Med Biol. 2006 Mar 21;51(6):1623-31. Epub 2006 Mar 1.

PMID:
16510967
18.

Lipid nanoparticles for skin penetration enhancement-correlation to drug localization within the particle matrix as determined by fluorescence and parelectric spectroscopy.

Lombardi Borgia S, Regehly M, Sivaramakrishnan R, Mehnert W, Korting HC, Danker K, Röder B, Kramer KD, Schäfer-Korting M.

J Control Release. 2005 Dec 10;110(1):151-63. Epub 2005 Nov 16.

PMID:
16297487
19.

Parelectric spectroscopy of drug-carrier-systems--distribution of carrier masses or activation energies.

Sivaramakrishnan R, Kankate L, Niehus H, Kramer KD.

Biophys Chem. 2005 Apr 22;114(2-3):221-8. Epub 2004 Dec 24.

PMID:
15829356
20.

Glucocorticoid entrapment into lipid carriers--characterisation by parelectric spectroscopy and influence on dermal uptake.

Sivaramakrishnan R, Nakamura C, Mehnert W, Korting HC, Kramer KD, Schäfer-Korting M.

J Control Release. 2004 Jul 7;97(3):493-502.

PMID:
15212881
21.

[A method of computerized evaluation of CT based treatment plants in external radiotherapy].

Heufelder J, Zink K, Scholz M, Kramer KD, Welker K.

Z Med Phys. 2003;13(4):231-9. German.

PMID:
14732952
22.

[Parelectric spectroscopy for noninvasive diagnosis of laryngeal tissue].

Mahlstedt K, Blaschke T, Kramer KD, Gross M.

Biomed Tech (Berl). 2002 Apr;47(4):70-5. German.

PMID:
12051135
23.

[Dielectric spectroscopy for noninvasive examination of corneal tissue].

Oltrup T, Bende T, Kramer KD, Jean B.

Biomed Tech (Berl). 1999 Apr;44(4):78-82. German.

PMID:
10379067
24.

Depression, disease severity, and sickle cell disease.

Wison Schaeffer JJ, Gil KM, Burchinal M, Kramer KD, Nash KB, Orringer E, Strayhorn D.

J Behav Med. 1999 Apr;22(2):115-26.

PMID:
10374138
25.

Dielectric spectroscopy as a sensor of membrane headgroup mobility and hydration.

Klösgen B, Reichle C, Kohlsmann S, Kramer KD.

Biophys J. 1996 Dec;71(6):3251-60.

26.

Influence of electromagnetic fields on the enzyme activity of rheumatoid synovial fluid cells in vitro.

Mohamed-Ali H, Kolkenbrock H, Ulbrich N, Sörensen H, Kramer KD, Merker HJ.

Eur J Clin Chem Clin Biochem. 1994 Apr;32(4):319-26.

PMID:
8038273
27.

Sickle cell mutual assistance groups and the health services delivery system.

Shelley B, Kramer KD, Nash KB.

J Health Soc Policy. 1994;5(3-4):243-59.

PMID:
10138761
28.

The sickle cell mutual assistance movement.

Kramer KD, Nash KB.

J Health Soc Policy. 1994;5(3-4):203-14.

PMID:
10138759
29.

Inhibition by manoalide of fMLP-stimulated elastase release from human neutrophils.

De Vries GW, Amdahl LD, Kramer KD, Wheeler LA.

Biochem Pharmacol. 1990 Dec 1;40(11):2487-90.

PMID:
2268367
30.

Modifying food purchases in supermarkets with modeling, feedback, and goal-setting procedures.

Winett RA, Kramer KD, Walker WB, Malone SW, Lane MK.

J Appl Behav Anal. 1988 Spring;21(1):73-80.

31.

[Principles of the clinical application of magnetic resonance tomography (MRT) in oral medicine. I: Basic principles of MRT].

Semmler W, Becker J, Schuster M, Kramer KD, Felix R.

Dtsch Z Mund Kiefer Gesichtschir. 1986 Jan-Feb;10(1):31-45. German. No abstract available.

PMID:
3481982
32.

[Antihypertensive combination-therapy with inositol nicotinate in essential hypertension].

Krämer KD, Ghabussi P, Hochrein H.

Med Welt. 1977 Jul 8;28(27):1198-1201. German. No abstract available.

PMID:
329049
33.

Hemodynamics and myocardial electrolyte (k+/na+) metabolism early in hemorrhagic shock during asphyxia.

Krämer KD, Kult J, Hochrein H.

Basic Res Cardiol. 1976 May-Jun;71(3):270-86.

PMID:
938439
34.

[Enteral availability and therapeutic activity of proscillaridin-4'-methyl ether (author's transl)].

Krämer KD, Hochrein H.

Arzneimittelforschung. 1976 Apr;26(4):579-83. German.

PMID:
989015
35.

[Dose-effect comparison of antihypertensive combinations with and without alpha-methyldopa].

Krämer KD, Ghabussi P, Lehmann HU, Hochrein H.

MMW Munch Med Wochenschr. 1975 Apr 4;117(14):579-82. German.

PMID:
806789
36.

[Long-term action of nitrites in coronary heart disease (author's transl)].

Wolf R, Beck OA, Krämer KD, Hochrein H.

Dtsch Med Wochenschr. 1975 Apr 4;100(14):735-42. German.

PMID:
805039
37.

[Enteral availability and suggested dosages for methyl proscillaridin in decompensated heart patients].

Krämer KD, Hochrein H.

Verh Dtsch Ges Inn Med. 1975;81:1669-71. German. No abstract available.

PMID:
1227053
38.

[Haemodynamic reactions to injection and subsequent infusion of phenytoin (author's transl)].

Beck OA, Wolf R, Krämer KD, Hochrein H.

Dtsch Med Wochenschr. 1974 Nov 8;99(45):2279-83. German. No abstract available.

PMID:
4448135
39.

[Dose determinations and enteral effectiveness of the pure lanata glycoside digoxine (Lanicor) in decompensated heart disease patients].

Krämer KD, Ghabussi P, Hochrein H.

MMW Munch Med Wochenschr. 1974 Aug 30;116(35):1505-8. German. No abstract available.

PMID:
4213781
40.

[Determination of the relative enteral activity of beta-methyl-digoxin in patients with heart failure (author's transl)].

Ghabussi P, Krämer KD, Hochrein H.

Med Klin. 1974 May 3;69(18):802-5. German. No abstract available.

PMID:
4837409
41.

[Suicidal digoxin intoxication with hyperkalaemia: report of a case (author's transl)].

Beck OA, Krämer KD, Hochrein H.

Dtsch Med Wochenschr. 1974 Apr 12;99(15):756-64. German. No abstract available.

PMID:
4834839
42.

[Tolerance increase of k-strophantin-alpha through d,l-alpha-tocopherol acetate. Clinical studies in patients with decompensated heart diseases].

Ghabussi P, Krämer KD, Hochrein H.

Arzneimittelforschung. 1974 Feb;24(2):202-5. German. No abstract available.

PMID:
4406371
43.

[Combined antihypertensive therapy using short and delayed-action saluretics. Studies on patients with essential hypertension].

Krämer KD, Ghabussi P, Vogt W, Hochrein H.

Med Welt. 1974 Jan 11;25(2):53-6. German. No abstract available.

PMID:
4814840
44.

[Effects and complications of antihypertensive combined therapy with furosemid-reserpin (author's transl)].

Krämer KD, Vogt W, Ghabussi P, Hochrein H.

Med Klin. 1973 Oct 5;68(40):1303-8. German. No abstract available.

PMID:
4765896
45.

[Clinical study on the subtoxic full effective and maintenance dose of digoxin under the influence of spironolactone. Studies on the decompensated heart patient].

Krämer KD, Ghabussi P, Hochrein H.

Arzneimittelforschung. 1973 Apr;23(4):508-11. German. No abstract available.

PMID:
4740227
46.

[Therapeutic value of the aldosterone antagonist potassium canrenoate in digitalis intoxication (clinical studies at an internal intensive ward)].

Krámer KD, Vogt W, Ghabussi P, Hochrein H.

Med Welt. 1973 Mar 23;24(12):462-4. German. No abstract available.

PMID:
4700879
47.

[Myocardial potassium content in hemorrhagic shock and its modification by digitalis].

Krämer KD, Kult J, Hochrein H.

Z Kreislaufforsch. 1972 Nov;61(11):1035-43. German. No abstract available.

PMID:
4656441
48.
49.

[Clinical studies of the oral and parenteral action of k-strophanthin-alpha in decompensated heart patients].

Krämer KD, Ghabussi P, Hochrein H.

Dtsch Med Wochenschr. 1972 Jun 2;97(22):870-7. German. No abstract available.

PMID:
4114343

Supplemental Content

Loading ...
Support Center